Publications by authors named "Z Argenyi"

Melanoma is a deadly skin cancer with rapidly increasing incidence worldwide. The discovery of the genetic drivers of melanomagenesis in the last decade has led the World Health Organization to reclassify melanoma subtypes by their molecular pathways rather than traditional clinical and histopathologic features. Despite this significant advance, the genomic and transcriptomic drivers of metastatic progression are less well characterized.

View Article and Find Full Text PDF

Palisaded encapsulated neuromas (PENs) are benign cutaneous nerve sheath proliferations that typically occur as flesh-colored papules solitarily on the head and neck in adults, with a slight predilection for females. Histopathologically, they are partially or completely encapsulated intradermal nodules with Schwann cells and axons in fascicles separated by clefts. Although these features are often characteristic, the hypercellular variant of PEN can pose a diagnostic challenge in distinguishing between other cellular neural and melanocytic lesions.

View Article and Find Full Text PDF
Article Synopsis
  • Talimogene laherparepvec (T-VEC) is an experimental viral therapy for treating advanced melanoma that cannot be surgically removed.
  • A study on a 63-year-old man revealed that T-VEC led to a complete response in his melanoma after other treatments failed, but it also raised concerns about immune-related side effects (irAEs).
  • This case is significant as it documents a new irAE (panniculitis) associated with T-VEC, highlighting the need for further understanding of these potential immune reactions in patients receiving this treatment.
View Article and Find Full Text PDF

Background: Appropriate use criteria (AUC) provide physicians guidance in test selection, and can affect health care delivery, reimbursement policy, and physician decision-making.

Objectives: The American Society of Dermatopathology, with input from the American Academy of Dermatology and the College of American Pathologists, sought to develop AUC in dermatopathology.

Methods: The RAND/UCLA appropriateness methodology, which combines evidence-based medicine, clinical experience, and expert judgment, was used to develop AUC in dermatopathology.

View Article and Find Full Text PDF